Among patients with familial amyloid polyneuropathy, a lethal, genetic neurodegenerative disease, use of the nonsteroidal anti-inflammatory agent diflunisal compared with placebo for 2 years reduced the rate of progression in neurological impairment and preserved quality of life, according to…
Nonsteroidal anti-inflammatory agent delays neuropathy progression, preserves quality of life
No comments:
Post a Comment